A recent study by UI scientists shows that a type of human gut bacteria is as effective as an approved drug in blocking multiple sclerosis-like symptoms in a mouse model of the disease.

A study led by E. Dale Abel, MD, PhD, suggests that blocking glucose metabolism in platelets might provide a target for reducing abnormal blood clotting in patients with diabetes.

We often hear about research behind the principles that we learned during the first two years of our medical school education. However, we often hear that some ideas have yet to be elucidated. For medical students, these are great opportunities for us to contribute to medical knowledge.

It’s more than a coincidence that a handful of researchers from Harvard recently migrated to the University of Iowa. They’re drawn by the Iowa Neuroscience Institute and its collaborative environment and support for young investigators.